Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Botulinum type A2 toxin - Shionogi

Drug Profile

Botulinum type A2 toxin - Shionogi

Alternative Names: 150kDa botulinum type A toxin - KM Biologics; A2NTX; Botulinum type A toxin (150kDa) - KM Biologics; LMW botulinum type A toxin; Low molecular weight botulinum type A toxin; NTX

Latest Information Update: 06 Nov 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Kaketsuken; University of Tokushima
  • Developer Kaketsuken; Shionogi; University of Tokushima
  • Class Analgesics; Antidepressants; Antimigraines; Antispasmodics; Bacterial proteins; Bacterial toxins; Botulinum toxins; Eye disorder therapies; Muscle relaxants; Skin disorder therapies; Urologics
  • Mechanism of Action Neuromuscular blocking agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Muscle spasticity
  • Discontinued Dystonia

Most Recent Events

  • 28 Dec 2017 No recent reports of development identified for clinical-Phase-Unknown development in Muscle-spasticity in Japan (Intradermal, Injection)
  • 11 Dec 2017 Discontinued - Clinical-Phase-Unknown for Dystonia in Japan (Intradermal) (Kaketsuken pipeline, December 2017)
  • 15 Mar 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top